Cargando…
Intestinal stenosis in Crohn’s disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets
BACKGROUND AND AIMS: Crohn’s disease (CD) can be complicated by intestinal fibrosis. Pharmacological therapies against intestinal fibrosis are not available. The aim of this study was to determine whether pathways involved in collagen metabolism are upregulated in intestinal fibrosis, and to discuss...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457685/ https://www.ncbi.nlm.nih.gov/pubmed/32922514 http://dx.doi.org/10.1177/1756284820952578 |
_version_ | 1783576045613481984 |
---|---|
author | van Haaften, Wouter Tobias Blokzijl, Tjasso Hofker, Hendrik Sijbrand Olinga, Peter Dijkstra, Gerard Bank, Ruud A. Boersema, Miriam |
author_facet | van Haaften, Wouter Tobias Blokzijl, Tjasso Hofker, Hendrik Sijbrand Olinga, Peter Dijkstra, Gerard Bank, Ruud A. Boersema, Miriam |
author_sort | van Haaften, Wouter Tobias |
collection | PubMed |
description | BACKGROUND AND AIMS: Crohn’s disease (CD) can be complicated by intestinal fibrosis. Pharmacological therapies against intestinal fibrosis are not available. The aim of this study was to determine whether pathways involved in collagen metabolism are upregulated in intestinal fibrosis, and to discuss which drugs might be suitable to inhibit excessive extracellular matrix formation targeting these pathways. METHODS: Human fibrotic and non-fibrotic terminal ileum was obtained from patients with CD undergoing ileocecal resection due to stenosis. Genes involved in collagen metabolism were analyzed using a microfluidic low-density TaqMan array. A literature search was performed to find potential anti-fibrotic drugs that target proteins/enzymes involved in collagen synthesis, its degradation and its recognition. RESULTS: mRNA expression of collagen type I (COL1A1, 0.76 ± 0.28 versus 37.82 ± 49.85, p = 0.02) and III (COL3A1, 2.01 ± 2.61 versus 68.65 ± 84.07, p = 0.02) was increased in fibrotic CD compared with non-fibrotic CD. mRNA expression of proteins involved in both intra- and extracellular post-translational modification of collagens (prolyl- and lysyl hydroxylases, lysyl oxidases, chaperones), collagen-degrading enzymes (MMPs and cathepsin-K), and collagen receptors were upregulated in the fibrosis-affected part. A literature search on the upregulated genes revealed several potential anti-fibrotic drugs. CONCLUSION: Expression of genes involved in collagen metabolism in intestinal fibrosis affected terminal ileum of patients with CD reveals a plethora of drug targets. Inhibition of post-translational modification and altering collagen metabolism might attenuate fibrosis formation in the intestine in CD. Which compound has the highest potential depends on a combination anti-fibrotic efficacy and safety, especially since some of the enzymes play key roles in the physiology of collagen. |
format | Online Article Text |
id | pubmed-7457685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-74576852020-09-11 Intestinal stenosis in Crohn’s disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets van Haaften, Wouter Tobias Blokzijl, Tjasso Hofker, Hendrik Sijbrand Olinga, Peter Dijkstra, Gerard Bank, Ruud A. Boersema, Miriam Therap Adv Gastroenterol Original Research BACKGROUND AND AIMS: Crohn’s disease (CD) can be complicated by intestinal fibrosis. Pharmacological therapies against intestinal fibrosis are not available. The aim of this study was to determine whether pathways involved in collagen metabolism are upregulated in intestinal fibrosis, and to discuss which drugs might be suitable to inhibit excessive extracellular matrix formation targeting these pathways. METHODS: Human fibrotic and non-fibrotic terminal ileum was obtained from patients with CD undergoing ileocecal resection due to stenosis. Genes involved in collagen metabolism were analyzed using a microfluidic low-density TaqMan array. A literature search was performed to find potential anti-fibrotic drugs that target proteins/enzymes involved in collagen synthesis, its degradation and its recognition. RESULTS: mRNA expression of collagen type I (COL1A1, 0.76 ± 0.28 versus 37.82 ± 49.85, p = 0.02) and III (COL3A1, 2.01 ± 2.61 versus 68.65 ± 84.07, p = 0.02) was increased in fibrotic CD compared with non-fibrotic CD. mRNA expression of proteins involved in both intra- and extracellular post-translational modification of collagens (prolyl- and lysyl hydroxylases, lysyl oxidases, chaperones), collagen-degrading enzymes (MMPs and cathepsin-K), and collagen receptors were upregulated in the fibrosis-affected part. A literature search on the upregulated genes revealed several potential anti-fibrotic drugs. CONCLUSION: Expression of genes involved in collagen metabolism in intestinal fibrosis affected terminal ileum of patients with CD reveals a plethora of drug targets. Inhibition of post-translational modification and altering collagen metabolism might attenuate fibrosis formation in the intestine in CD. Which compound has the highest potential depends on a combination anti-fibrotic efficacy and safety, especially since some of the enzymes play key roles in the physiology of collagen. SAGE Publications 2020-08-29 /pmc/articles/PMC7457685/ /pubmed/32922514 http://dx.doi.org/10.1177/1756284820952578 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research van Haaften, Wouter Tobias Blokzijl, Tjasso Hofker, Hendrik Sijbrand Olinga, Peter Dijkstra, Gerard Bank, Ruud A. Boersema, Miriam Intestinal stenosis in Crohn’s disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets |
title | Intestinal stenosis in Crohn’s disease shows a generalized
upregulation of genes involved in collagen metabolism and recognition that could
serve as novel anti-fibrotic drug targets |
title_full | Intestinal stenosis in Crohn’s disease shows a generalized
upregulation of genes involved in collagen metabolism and recognition that could
serve as novel anti-fibrotic drug targets |
title_fullStr | Intestinal stenosis in Crohn’s disease shows a generalized
upregulation of genes involved in collagen metabolism and recognition that could
serve as novel anti-fibrotic drug targets |
title_full_unstemmed | Intestinal stenosis in Crohn’s disease shows a generalized
upregulation of genes involved in collagen metabolism and recognition that could
serve as novel anti-fibrotic drug targets |
title_short | Intestinal stenosis in Crohn’s disease shows a generalized
upregulation of genes involved in collagen metabolism and recognition that could
serve as novel anti-fibrotic drug targets |
title_sort | intestinal stenosis in crohn’s disease shows a generalized
upregulation of genes involved in collagen metabolism and recognition that could
serve as novel anti-fibrotic drug targets |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457685/ https://www.ncbi.nlm.nih.gov/pubmed/32922514 http://dx.doi.org/10.1177/1756284820952578 |
work_keys_str_mv | AT vanhaaftenwoutertobias intestinalstenosisincrohnsdiseaseshowsageneralizedupregulationofgenesinvolvedincollagenmetabolismandrecognitionthatcouldserveasnovelantifibroticdrugtargets AT blokzijltjasso intestinalstenosisincrohnsdiseaseshowsageneralizedupregulationofgenesinvolvedincollagenmetabolismandrecognitionthatcouldserveasnovelantifibroticdrugtargets AT hofkerhendriksijbrand intestinalstenosisincrohnsdiseaseshowsageneralizedupregulationofgenesinvolvedincollagenmetabolismandrecognitionthatcouldserveasnovelantifibroticdrugtargets AT olingapeter intestinalstenosisincrohnsdiseaseshowsageneralizedupregulationofgenesinvolvedincollagenmetabolismandrecognitionthatcouldserveasnovelantifibroticdrugtargets AT dijkstragerard intestinalstenosisincrohnsdiseaseshowsageneralizedupregulationofgenesinvolvedincollagenmetabolismandrecognitionthatcouldserveasnovelantifibroticdrugtargets AT bankruuda intestinalstenosisincrohnsdiseaseshowsageneralizedupregulationofgenesinvolvedincollagenmetabolismandrecognitionthatcouldserveasnovelantifibroticdrugtargets AT boersemamiriam intestinalstenosisincrohnsdiseaseshowsageneralizedupregulationofgenesinvolvedincollagenmetabolismandrecognitionthatcouldserveasnovelantifibroticdrugtargets |